Presentation TCT 2021

TCT 703: Concomitant Transcatheter Mitral-Valve-in-Valve (MViV) with Left Atrial Appendage (LAA) Occlusion Device in a High-Risk Patient Unable to Tolerate Anticoagulation

Presenter: Peter Sayegh

November 04, 2021

REGISTER for free or LOG IN to view this content

TCT 703: Concomitant Transcatheter Mitral-Valve-in-Valve (MViV) with Left Atrial Appendage (LAA) Occlusion Device in a High-Risk Patient Unable to Tolerate Anticoagulation

Structural Heart

TCT 2021

Mitral Valve

Up Next

Presentation TCT 2021

TCT 599: Caval Valve Implantation (CAVI) as a Life Saving Intervention in Severe Tricuspid and Pulmonary Regurgitation in Patient With a Neuroendocrine Tumour (Carcinoid Syndrome)

Presenter: Nihar Mehta

November 04, 2021

More slides +

Presentation TCT 2021

TCT 600: Transcatheter Valve Implantation Into Dysfunctional Surgical Bioprosthesis Of Tricuspid Valve in 5-Year Old Patient With Ebstein's Anomaly And Severe Comorbidities

Presenter: Andrei Baev

November 04, 2021

Presentation TCT 2021

TCT 603: First Report: Long Native Leaflet Causing "Leaflet Overhang" Causing Severe Central Tricuspid Regurgitation After Valve-In-Ring With Sapien 3 Valve

Presenter: Pradeep Yadav

November 04, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.